CME Group Inc is a publicly traded company operating in the Financial Services industry. Its shares trade on NASDAQ NMS - GLOBAL MARKET under the ticker CME, with a market capitalization of approximately $94.81 billion. A full business summary isn’t available for this company yet — the figures and signals on this page…
An institutional-grade, numbers-driven thesis on CME — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates CME Group Inc (CME) 63/100 with a 12-month base-case forecast of $302.99 — +14.9% versus the current price of $263.66. CME Group Inc trades at $263.66 in the Financial Services sector, with a market capitalisation of $94.81B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for CME is $302.99, implying +14.9% versus the current price. The model's 12-month scenario range runs from $288.40 (bear) to $337.99 (bull), with a base case of $302.99.
On the fundamentals, CME Group shows a P/E of 22.3, trailing revenue of $12.55B, revenue growth of +16.6% YoY, a dividend yield of 1.91%. This page also tracks CME's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
CME currently carries a TradersQuant composite score of 63/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "hold". Our 12-month price target of $302.99 implies +14.9% from $263.66. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for CME is $302.99, about +14.9% versus the latest price of $263.66. Consensus is based on 21 analysts.
TradersQuant's 12-month model forecast for CME is a base case of $302.99, ranging from $288.40 (bear) to $337.99 (bull), an expected return of +14.9%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for CME over the next 12 months is $302.99 in the base case (bear $288.40, bull $337.99), versus today's price of $263.66. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for CME — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates CME's fair value at $346.84, implying +31.6% of expected upside versus the current price.
Yes — CME Group pays a dividend yielding 1.91% (about $5.04 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
